<?xml version="1.0" encoding="UTF-8"?>
<ref id="B111-vaccines-08-00273">
 <label>111.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hannaman</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Dupuy</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Ellefsen</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Schmaljohn</surname>
    <given-names>C.S.</given-names>
   </name>
  </person-group>
  <article-title>A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation</article-title>
  <source>Vaccine</source>
  <year>2016</year>
  <volume>34</volume>
  <fpage>3607</fpage>
  <lpage>3612</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.04.077</pub-id>
  <pub-id pub-id-type="pmid">27206386</pub-id>
 </element-citation>
</ref>
